Clinical Trial Update: Omeprazole 20 mg in Patients With Laryngopharyngeal reflux and Comorbid Chronic Rhinosinusitis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating omeprazole 20 mg in patients with laryngopharyngeal reflux and comorbid chronic rhinosinusitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Laryngopharyngeal Reflux
• Rhinosinusitis

Drugs mentioned

• Omeprazole 20 mg (Omeprazole 20 mg)

Snippet

Sponsor: Children's Hospital Srebrnjak | Conditions: Laryngopharyngeal Reflux, Chronic Rhinosinusitis (Diagnosis) | Phase 4 | Status: COMPLETED